Drug intelligence / Profile preview

Sheng-qi-yi-shen Formula

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Sheng-qi-yi-shen Formula is a Traditional Chinese Medicine (TCM) formula investigated for its therapeutic effects in allergic conditions, including allergic asthma and allergic rhinitis. It is traditionally understood to address "deficiency of lung and kidney yang" (肺肾阳虚型) in TCM theory. Clinical studies suggest it can modulate immune responses, affecting immunoglobulin levels (IgE, IgM, IgA) and lymphocyte expression, and may help to inhibit inflammatory responses and improve lung function in patients with allergic respiratory diseases.

Other names: Shengyang Yishen Decoction

Beyond the preview

Go deeper on Sheng-qi-yi-shen Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sheng-qi-yi-shen Formula.

Explore the full profile